AstraZeneca (AZNL)

10,635.00p
   
  • Change Today:
      2.16p
  • 52 Week High: 13,250.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 438,592
  • Market Cap: £134,444m

Latest ShareCast News

Germany's Cheplapharm pays AstraZeneca $200m for Atacand rights

By Frank Prenesti

Date: Monday 01 Oct 2018

(Sharecast News) - AstraZeneca said it had agreed a $200m deal with Germany's Cheplapharm Arzneimittel for the European commercial rights to Atacand and Atacand Plus heart and hypertension treatments.

Sunday share tips: AstraZeneca, Genus, 'Dogs of the Footsie'

By Josh White

Date: Sunday 30 Jul 2017

(ShareCast News) - In the Mail on Sunday, Midas' Joanne Hart looked at the paper's so-called 'Dogs of the Footsie' - its experimental portfolio of the ten highest-yielding shares on the benchmark index.

AstraZeneca co-develops treatment for Alzheimer's disease

By Bianca Boorer

Date: Tuesday 13 Dec 2016

(ShareCast News) - Pharmaceutical giant AstraZeneca has teamed up with American counterpart Eli Lilly to co-develop a treatment for Alzheimer's disease (AD).

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,635.00p
Change Today 2.16p
% Change 2.07 %
52 Week High 13,250.00p
52 Week Low 9,642.00p
Volume 438,592
Shares Issued 1,264.16m
Market Cap £134,444m

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 30-May-2025

Time Volume / Share Price
16:29 418 @ 10,637.00p
16:29 18 @ 10,640.00p
16:29 46 @ 10,640.00p
16:29 400 @ 10,638.00p
16:29 46 @ 10,638.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page